Daiichi Sankyo, Kowa sales and marketing update

Daiichi and Kowa said the companies terminated their Japanese commercialization partnership for Kowa's cholesterol drug Livalo pitavastatin and Daiichi's hypertension drug Olmetec olmesartan followin...